Pharmaceutical Business review

Oxis appoints David Saloff as CEO

In his career, he has founded three companies, two of which went public and a third that was sold to a healthcare products company.

Saloff was the co-founder and co-chief executive officer of Ivivi Technologies, which developed and manufactured advanced non-drug anti-inflammatory devices to treat chronic and acute wounds and post-surgical pain.

Oxis Chairman Anthony Cataldo said in addition to his managerial experience, David has an outstanding track record of effectively raising and deploying capital, and building shareholder value.